Novel Antimicrobial Agents for Gram-Negative Pathogens.
Karvouniaris M, Almyroudi MP, Abdul-Aziz MH, Blot S, Paramythiotou E, Tsigou E, Koulenti D.
Karvouniaris M, et al.
Antibiotics (Basel). 2023 Apr 16;12(4):761. doi: 10.3390/antibiotics12040761.
Antibiotics (Basel). 2023.
PMID: 37107124
Free PMC article.
Review.
There are new antimicrobials that became commercially available during the last five years, namely, cefiderocol, imipenem-cilastatin-relebactam, eravacycline, omadacycline, and plazomicin. Furthermore, other agents are in advanced development, having reached phase 3 clinic …
There are new antimicrobials that became commercially available during the last five years, namely, cefiderocol, imipenem-cilastatin-relebac …